ArticleFrontiers in oncology2020

Successful Treatment of Early Relapsed High-Risk AML After Allogeneic Hematopoietic Stem Cell Transplantation With Biomodulatory Therapy.

Anna-Sophia Kattner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.